Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
Facility significantly increases future financial and operational flexibilityUp to $200M available, with $30 million drawn at close and additional $80...
Day: November 8, 2024
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Vera Therapeutics to Participate at Upcoming Investor Conferences
BRISBANE, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on...
Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and...
RaySearch Laboratories: Interim report July – September 2024
STOCKHOLM, Nov. 8, 2024 /PRNewswire/ -- THIRD QUARTER (JULY - SEPTEMBER 2024) Order intake SEK 253.4 M (240.7)Net sales SEK...
Aulisa® Medical Expands Access with New Leasing Options for Procuring Advanced Monitoring Solutions
PALO ALTO, Calif., Nov. 7, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in FDA-cleared, wearable, wireless continuous vital...
Shanghai thriving as global investment hub
BEIJING, Nov. 7, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn： The 2024 Shanghai City Investment Promotion Conference, held on Nov...